Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
TIMM 2023: schimmels, ‘C. auris’ én de inzichten van COVID-19 in de spotlights
dec 2023 | Schimmelinfecties